Combretastatin A4-β-Galactosyl Conjugates for Ovarian Cancer Prodrug Monotherapy.

about

Combretastatin A4-β-Galactosyl Conjugates for Ovarian Cancer Prodrug Monotherapy.

Item

http://www.wikidata.org/entity/Q50353096

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Combretastatin A4-β-Galactosyl Conjugates for Ovarian Cancer Prodrug Monotherapy.

@en

Combretastatin A4-β-Galactosyl Conjugates for Ovarian Cancer Prodrug Monotherapy.

@nl

type

Item

label

Combretastatin A4-β-Galactosyl Conjugates for Ovarian Cancer Prodrug Monotherapy.

@en

Combretastatin A4-β-Galactosyl Conjugates for Ovarian Cancer Prodrug Monotherapy.

@nl

prefLabel

Combretastatin A4-β-Galactosyl Conjugates for Ovarian Cancer Prodrug Monotherapy.

@en

Combretastatin A4-β-Galactosyl Conjugates for Ovarian Cancer Prodrug Monotherapy.

@nl

P1476

Combretastatin A4-β-Galactosyl Conjugates for Ovarian Cancer Prodrug Monotherapy.

@en

P2093

Tomohiro Doura

http://www.w3.org/2001/XMLSchema#string

Yasumitsu Ogra

http://www.w3.org/2001/XMLSchema#string

P2860

Sensitive β-galactosidase-targeting fluorescence probe for visualizing small peritoneal metastatic tumours in vivo.

Beta-D-glycosylamidines: potent, selective, and easily accessible 1-glycosidase inhibitors.

The biology of ovarian cancer: new opportunities for translation

Cancer of the ovary.

Enzyme activity in invasive tumors of human breast and colon.

Lipophilicity in drug discovery.

Self-immolative spacers: kinetic aspects, structure-property relationships, and applications.

Synthesis and antitumor-evaluation of cyclopropyl-containing combretastatin analogs.

Elongated multiple electronic cascade and cyclization spacer systems in activatible anticancer prodrugs for enhanced drug release.

Synthesis and biological evaluation of novel prodrugs of anthracyclines for selective activation by the tumor-associated protease plasmin.

P304

211-214

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACSMEDCHEMLETT.6B00427

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kazuaki Takahashi

Noriyuki Suzuki

P577

2017-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28197314

http://www.w3.org/2001/XMLSchema#string

P921

ovarian cancer

P932

5304305

http://www.w3.org/2001/XMLSchema#string